Lionco Pharmaceutical Group Co.,Ltd. (SHA:603669)
6.33
+0.32 (5.32%)
Sep 30, 2026, 3:00 PM CST
| Market Cap | 4.45B +15.5% |
| Revenue (ttm) | 408.33M -0.4% |
| Net Income | -136.39M |
| EPS | -0.19 |
| Shares Out | 703.55M |
| PE Ratio | n/a |
| Forward PE | n/a |
| Dividend | n/a |
| Ex-Dividend Date | n/a |
| Volume | 35,874,676 |
| Open | 6.02 |
| Previous Close | 6.01 |
| Day's Range | 5.93 - 6.38 |
| 52-Week Range | 4.01 - 8.40 |
| Beta | 0.23 |
| Analysts | n/a |
| Price Target | n/a |
| Earnings Date | Oct 24, 2026 |